"Introduction
The rapid worldwide spread of COVID-19 motivated medical professionals to pursue and authenticate appropriate remedies and treatment protocols. This article aims to analyze the potential benefits of one treatment protocol developed by a group of care providers caring for severe COVID-19 patients.
Methods
The clinical findings of COVID-19 patients who were transferred to a specialized care hospital after unsuccessful treatment in previous institutions, were analyzed. The specialized care hospital used a treatment protocol including hydroxyurea, a medication commonly used for sickle cell treatment, to improve respiratory distress in the COVID-19 patients. None of the COVID-19 patients included in the analyzed data were diagnosed with sickle cell, and none had previously taken hydroxyurea for any other conditions.
Results
In all presented cases, patients reverted to their baseline respiratory health after treatment with the hydroxyurea protocol. There was no significant difference in the correlation between COVID-19 and hydroxyurea. However, deaths were extremely low for those taking hydroxyurea.
Conclusions
Fatality numbers were extremely low for those taking hydroxyurea; death could be attributed to other underlying issues."
" All of these patients had been referred to palliative treatment with a prognosis of little to no chance of improvement from the referring hospitals. However, the patients and patient advocates wanted to continue looking for facilities that would offer curative treatment with the hopes of improvement. That led to their care being transferred to the specialized care hospital. None of the patients observed had been diagnosed with sickle cell disease or had any other prior treatment involving hydroxyurea.....
Nine patients were observed, both male and female, ranging in age from 51-76. All patients were diagnosed with COVID-19 and had moderate to severe hypoxemia.. Eight of the nine patients were intubated prior to admission to the specialty hospital; one of the eight intubated patients had the tube removed prior to being transferred to the specialty hospital. All seven of the observed intubated patients had their tubes after starting the hospital’s COVID-19 treatment protocol. The average number of days on the COVID-19 treatment protocol before tube removal was 14 days.
All nine patients improved sufficiently to be discharged to a rehabilitation facility. Upon discharge, all patients had returned to their respiratory health status prior to their COVID-19 diagnosis. The average number of days on the COVID-19 treatment protocol until discharge was 19 days."
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647674/
Any thoughts from our resident doc(s)?
N.B. I did write a few more comments but, on reflection, deleted them so as not to offend. I know, I know, it's never stopped me in the past.


